期刊文献+

国外制药企业环保制度及对我国的借鉴意义 被引量:8

Environmental protection systems of pharmaceutical enterprise in developed countries and the enlightenment to China
原文传递
导出
摘要 本文分析探讨了国外发达国家先进的制药企业环保制度和政策,并与我国制药企业环保制度进行对比。虽然我国对于制药企业的环保体系已经基本建立,但还存在环保法律责任规定不足、排污许可证制存在制度缺陷、环评制度不合理、制药工业污染防治技术政策不严格及信息公开与公众参与程度不够等问题。建议我国应健全制药企业环境保护管理机制,加强排污交易权在我国的可行性研究,注重绿色科技创新,调整产品结构,通过加强教育提升制药企业环保意识以及全民的环境监督意识,从而促进制药企业走上绿色发展道路。 In this paper, we analyzed and discussed the advanced environmental protection systems pharmaceutical enterprise in developed countries, and compared these systems with the system in China. Althou the environmental protection system of pharmaceutical enterprise has basically been built in China, there still e of gh xit problems such as the lack of responsibility regulations on environmental legal, the system deficiency on permitting system of pollutant discharge, the undemanding on pollution prevention technical policy of pharmaceutical industry, and the insufficient degree of information publication and public participation. Therefore, we recommend that the environmental protection systems of pharmaceutical enterprise should be perfected, the feasibility research of emission trading right should be strengthened in China, green technology innovation should be emphasized, the product structure should be readjusted, and the environmental awareness of the pharmaceutical enterprise and the environmental supervision sense of whole nation should be promoted. These may promote green development of the pharmaceutical enterprise.
机构地区 郑州大学药学院
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第4期381-386,共6页 Chinese Journal of New Drugs
关键词 国外制药企业 环境保护 排污交易权 排污许可证 绿色制药 foreign pharmaceutical companies environmental protection emissions trading rights discharge permit green pharmaceuticals
  • 相关文献

参考文献15

  • 1EPA. Enviromnental Assessments & Environmental hnpact State- ments [ EB/OL]. ( 2013 - 01 ). http ://www. epa. gov/reg3esdl / nepa/eis, htm.
  • 2江莹.美国制药企业环保监管的启示[J].现代商贸工业,2012,24(8):42-43. 被引量:2
  • 3EPA. Clean Air Interstate Rule (CAIR)[EB/OL]. (2013 - 01 ). http ://www. epa. gov/CAIR/.
  • 4EPA. Summary of the Toxic Substances Control Act[ EB/OL]. (2013 -02 ). http ://www. epa. gov/lawsregs/laws/tsca, html.
  • 5EPA. Pharmaceuticals and Personal Care Products (PPCPs) [ EB/OL ]. ( 2012 - 02). http ://www. epa. gov/ppcp/.
  • 6环境保护部.《制药工业污染防治技术政策(征求意见稿)》[EB/OL]. (2009 - 10). http://kjs, mep. gov. cn/hjbhbz/ bzwb/wrfzjszc/201203/t20120319_224790, htm.
  • 7EPA. 2011 TRI National Analysis[EB/OL]. (2013 -01). ht- tp ://www. epa. gov/tri/tridata/tri[ 1/nationalana|ysis/index. htm.
  • 8EPA. Toxics Release Inventory Program : Releases and Other Man- agement of Toxic Chemicals on Near Tribal Lands [ EB/OL ]. ( 2012 - 06 ). http ://www. epa. gov/tri/stakeholders/trlbal/TRI Tribal_Webinar_Presentation_9. 6.12. pdf.
  • 9EPA. Acid Rain Program [ EB/OL ]. ( 2012 - 07 ). http ://www. epa. gov/airmarkets/progsregs/arp/index, html.
  • 10EPA. Clean Air Interstate Rule, Acid Rain Program, and Former NOx Budget Trading Program 2011 Progress Report. [ EB/OL]. (2012 - 04 ). http ://www. epa. gov/airmarkets/progress/ARP- CAIR11_01. html.

二级参考文献5

共引文献5

同被引文献56

引证文献8

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部